๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Associations between serum lipids and hepatitis C antiviral treatment efficacy

โœ Scribed by Darmendra Ramcharran; Abdus S. Wahed; Hari S. Conjeevaram; Rhobert W. Evans; Tianyi Wang; Steven H. Belle; Leland J. Yee; for the Virahep-C Study Group


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
376 KB
Volume
52
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Efficacy, predictors of response, and po
โœ Marina Berenguer; Antonio Palau; Alberto Fernandez; Salvador Benlloch; Victoria ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 110 KB ๐Ÿ‘ 1 views

There are unresolved issues regarding sustained virological response (SVR), tolerance and risk of rejection following antiviral therapy in liver transplantation (LT). The aim of our study was to determine efficacy, rejection risk and factors associated with SVR. HCV-infected LT patients with at leas

Association between high serum alanine a
โœ Kazuo Tarao; Yasushi Rino; Shinichi Ohkawa; Akio Shimizu; Setsuo Tamai; Kaoru Mi ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 151 KB ๐Ÿ‘ 2 views

Many studies have demonstrated in animal experiments that persistent inflammation may accelerate the development of carcinoma. In this article, the question of whether the persistent elevation of serum alanine aminotransferase (ALT) levels (which represents the inflammatory necrosis of hepatocytes)

Relationship between the recurrence of h
โœ Kazuo Tarao; Shoji Takemiya; Setsuo Tamai; Yukio Sugimasa; Shinichi Ohkawa; Mako ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 172 KB ๐Ÿ‘ 2 views

## Background: The relationship between the recurrence of hepatocellular carcinoma (hcc) and the serum alanine aminotransferase (alt) level was studied in hepatectomized patients with hepatitis c virus (hcv)-associated cirrhosis and hcc. ## Methods: Twenty-six hepatectomized patients with hcv-ass

Determinants of relapse after a short (1
โœ Alessandra Mangia; Nicola Minerva; Donato Bacca; Raffaele Cozzolongo; Ernesto Ag ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 142 KB ๐Ÿ‘ 2 views

In hepatitis C virus (HCV) genotypes 2 and 3 patients, the high rate of relapse after 12 to 16 weeks of antiviral therapy is the main concern for shortening treatment duration. This study was undertaken to delineate predictors of relapse after short treatment in patients with undetectable HCV RNA at